PARP Inhibitors in Advanced Prostate Cancer: Overcoming Global Challenges in Testing and Treatment

Learn strategies to optimize treatment with PARP inhibitors for patients with advanced prostate cancer, including biomarker testing to inform therapy choice and current guideline recommendations, through a certified on-demand webcast with accompanying downloadable slides, a ClinicalThought commentary, and an infographic.

Share

Program Content

Activities

PARP Inhibitors Prostate Cancer Global
PARP Inhibitors in Advanced Prostate Cancer: Overcoming Global Challenges in Testing and Treatment
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: May 14, 2024

Expires: May 13, 2025

Activities

PARP Inhibitors in Prostate Cancer Resource
PARP Inhibitors in Advanced Prostate Cancer: Molecular Testing and Treatment at a Glance
PDF
Congratulations: You achieved a completion on 04/09/2022

Released: May 24, 2024

Expires: May 23, 2025

Activities

PARPi in Advanced PC
PARP Inhibitors in Advanced Prostate Cancer: Overcoming Global Challenges in Testing and Treatment
Video
Congratulations: You achieved a completion on 04/09/2022

Released: June 03, 2024

Expires: June 02, 2025

Activities

PARPi for Advanced Prostate Cancer
PARP Inhibitors for Advanced Prostate Cancer: Global Opportunities and Challenges
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: July 11, 2024

Expires: July 10, 2025

Faculty

cover img faculity

Karim Fizazi, MD, PhD

Full Professor
Cancer Medicine
Gustave Roussy
Villejuif, France

cover img faculity

Joaquin Mateo, MD, PhD

Medical Oncology Department
Vall d’Hebron University Hospital
Group Leader
Vall d’Hebron Institute of Oncology
Barcelona, Spain

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC

Supporters

Supported by an educational grant from Pfizer Inc.

Pfizer Inc.